NeuroOne (NMTC) CEO Rosa David A Receives 68,000-Share Award

What Happened
Rosa David A, CEO & President and a director of NeuroOne Medical Technologies Corp (NMTC), was granted 68,000 shares on 2026-08-28 as an equity award (transaction code A). The shares were reported at $0.00 per share (no cash paid at grant), indicating a compensatory award such as restricted stock or RSUs rather than an open-market purchase.

Key Details

• Transaction date: 2026-08-28; reported on Form 4 filed 2026-08-28 (timely filing).
• Amount: 68,000 shares granted at $0.00 per share (derivative/award).
• Shares owned after the transaction: not specified in the filing.
• Vesting (footnote): 25% vests on August 28, 2027; the remaining 75% vests in 12 equal quarterly installments thereafter.
• Filing type: Award/Grant (A); no sale or purchase of shares reported.

Context
Grants like this are typically part of executive compensation and do not represent an open-market buy or sell. Because the award vests over time, the economic benefit to the insider depends on continued service and future vesting dates. This kind of transaction is informational for investors but does not by itself signal a personal cash investment in the stock.